Merck Cholesterol Drug Fails in Study

Published December 20, 2012

Merck Cholesterol Drug Fails in Study

Filed under: residential drug treatment programs

Merck filed for FDA approval of a new sleep drug, Suvorexant, billed as promoting sleep with fewer side effects than rivals, late this year, and will apply for approval of osteoporosis treatment Odanacatib in the first half of 2013. Merck, which spent …
Read more on Wall Street Journal

FDA issues warning over Hepatitis C drug

Filed under: residential drug treatment programs

The Food and Drug Administration is warning patients receiving treatment for hepatitis C with a triple drug regimen using Incevik, or telepriver, to be aware of a potentially dangerous, even fatal skin reaction. The FDA on Wednesday announced it has …
Read more on ArmyTimes.com

AG: Drug treatment exec embezzled 0K

Filed under: residential drug treatment programs

Attorney General Eric Schneiderman announced the arrest of 820 River Street executive Dennis Bassat for allegedly embezzling at least $ 200,000 from the Troy-based not-for-profit drug treatment organization over a four-year period ending in 2011. Bassat …
Read more on Albany Times Union (blog)